Cita APA

Alba, E., Albanell Mestres, J., Haba-Rodríguez, J. d. l., Barnadas, A., Calvo, L., Sánchez-Rovira, P., . . . Lluch, A. (2014). Trastuzumab or lapatinib with standard chemotherapy for HER2-positive breast cancer: Results from the GEICAM/2006-14 trial.

Citación estilo Chicago

Alba, Emilio, et al. Trastuzumab or Lapatinib With Standard Chemotherapy for HER2-positive Breast Cancer: Results From the GEICAM/2006-14 Trial. 2014.

Cita MLA

Alba, Emilio, et al. Trastuzumab or Lapatinib With Standard Chemotherapy for HER2-positive Breast Cancer: Results From the GEICAM/2006-14 Trial. 2014.